MarketInOut Stock Screener Log In | Sign Up

NeuroScientific Biopharmaceuticals Ltd

Healthcare • Biotechnology • Quote as of 10/27/2026
NeuroScientific Biopharmaceuticals Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
Market Capitalization21.82 mln
Float153 mln
Earnings Date03/03/2027

Piotroski F-Score

2 / 9
Weak

Relative Strength

28 / 100
Underperforming

Debt / Equity

0.01
Debt-free

ROE

-29.29
Deeply negative

ROA

-28.85
Deeply negative

Business Description

Founded in Perth, Australia in 2002, this company focuses on creating new medicines for diseases that affect the brain and nervous system. Their most advanced drug, EmtinB, is being developed to help patients suffering from eye conditions like glaucoma. The company is also working on a separate technology called StemSmart, aimed at treating disorders where the immune system causes harmful inflammation in the body.

Key Fundamentals

EPS-0.01
ROE-29.29
RPS0.00
ROIC-46.84
ROA-28.85
Interest Cover-1,624
EBITDA, mln-3.71
EV / EBITDA-4.29
EV / EBIT-3.12
Revenue, mln0.40
EV / Revenue42.92

Quote Details

Last 0.054
Change 0.002 (3.85%)
Open 0.058
Volume 209,535
Turnover 11,315
Average Volume 126,993

Financial Ratios

Leverage Ratio1.03
Current Ratio14.27
Price / Book1.61
Price / Tangible Book6.00
Debt / Equity0.01

Financial Strength

Piotroski F-Score 2 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -6.9% 19 / 100   
1 Month -12.9% 29 / 100   
2 Months -16.92% 26 / 100   
6 Months -53.04% 9 / 100   
1 Year -64% 9 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog